July 2 (Reuters) - The U.S. Food and Drug Administration

said on Tuesday it had warned a website called ozempen.com on

Tuesday against unlawfully selling versions of Novo Nordisk's

weight-loss drugs.

The FDA said the website was offering unapproved versions of

obesity and diabetes drugs Ozempic and Wegovy.

"These products are only available pursuant to a

prescription from a licensed practitioner," the health regulator

said.